<DOC>
	<DOCNO>NCT00613964</DOCNO>
	<brief_summary>Carperitide ( alpha-human atrial natriuretic peptide ) improve systemic hemodynamics patient heart failure vasodilatory action , natriuretic action , inhibition renin-angiotensin-aldosterone system widely-used Japan . However , paucity report available effect carperitide short long-term prognosis patient cardiac renal failure . The purpose study evaluate effect carperitide therapy short long-term prognosis patient cardiac renal failure , comparison standard therapy .</brief_summary>
	<brief_title>The Effects Carperitide Short Long-term Prognosis Patients With Both Cardiac Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Sodium Potassium Chloride Symporter Inhibitors</mesh_term>
	<criteria>Heart failure etiology , diagnose accord Framingham criterion Estimated GFR &lt; /= 60 ml/min/1.73 m2 ) Severe heart failure require percutaneous cardiopulmonary bypass support ( PCPS ) Endstage renal failure maintenance dialysis Severe hepatic dysfunction Severe anemia Allergic history carperitide Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Natriuretic Peptides</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Renal Failure</keyword>
</DOC>